As the global economy recovers in 2021 and the supply of the industrial chain improves, the Pharmacogenomics market will undergo major changes. The global pharmacogenomics market size was USD 5,680 Mn in 2022 and is likely to reach USD 11,800 Mn by 2031, expanding at a CAGR of 8.50% during 2023?2031.

The global Pharmacogenomics industry report provides top-notch qualitative and quantitative information including: Market size (2018-2022 value and 2023 forecast). The report also contains descriptions of key players, including key financial indicators and market competitive pressure analysis.

The report also assesses key opportunities in the market and outlines the factors that are and will drive the growth of the industry. Taking into account previous growth patterns, growth drivers, and current and future trends, we also forecast the overall growth of the global Pharmacogenomics market during the next few years. Market research reports are an essential resource for businesses seeking to maximize the market potential. The report provides extensive data, insights, and analysis to enable businesses to make informed decisions, drive growth, and achieve success.

Highlights-Regions

The Pharmacogenomics market can be split based on product types, major applications, and important regions as follows:

North America
Europe
China
Japan
Southeast Asia
India
Korea

Player list
Thermo Fisher Scientific Inc.
Invitae Corporation
F. Hoffmann-La Roche Ltd
Myriad Genetics, Inc.
Exact Sciences Corporation
Mesa Labs, Inc.
23andMe, Inc.
Laboratory Corporation of America Holdings.
QIAGEN
Admera Health
Abbott

Types list
Microarray
DNA Sequencing
Polymerase Chain Reaction
Others

Application list
Hospitals
Academic Institutes
Research Organizations